Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.72 USD | +4.11% | +0.51% | +7.89% |
May. 31 | Needham Trims Price Target on Celcuity to $23 From $24, Maintains Buy Rating | MT |
May. 30 | Sector Update: Health Care Stocks Mixed Pre-Bell Thursday | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 9.76M | Capitalization | 555M |
---|---|---|---|---|---|
Net income 2024 * | -94M | Net income 2025 * | -134M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 56.8 x |
P/E ratio 2024 * |
-5.77
x | P/E ratio 2025 * |
-4.64
x | Employees | 55 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 72.3% |
Latest transcript on Celcuity Inc.
1 day | +4.11% | ||
1 week | +0.51% | ||
Current month | -0.51% | ||
1 month | -0.32% | ||
3 months | +1.03% | ||
6 months | +7.16% | ||
Current year | +7.89% |
Managers | Title | Age | Since |
---|---|---|---|
Lance Laing
FOU | Founder | 62 | 11-12-31 |
Brian Sullivan
CEO | Chief Executive Officer | 62 | 11-12-31 |
Vicky Hahne
DFI | Director of Finance/CFO | 57 | 17-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Brian Sullivan
CEO | Chief Executive Officer | 62 | 11-12-31 |
Richard Nigon
BRD | Director/Board Member | 76 | 16-12-31 |
David Dalvey
BRD | Director/Board Member | 65 | 14-01-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +3.86% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 15.8 | +4.64% | 246,228 |
24-05-30 | 15.1 | +1.75% | 1,948,472 |
24-05-29 | 14.84 | -2.11% | 80,916 |
24-05-28 | 15.16 | -3.07% | 106,340 |
24-05-24 | 15.64 | -1.39% | 76,844 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.89% | 552M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- CELC Stock